These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 9107160)

  • 1. Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
    Demopoulos L; Yeh M; Gentilucci M; Testa M; Bijou R; Katz SD; Mancini D; Jones M; LeJemtel TH
    Circulation; 1997 Apr; 95(7):1764-7. PubMed ID: 9107160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of carvedilol on the benefits of physical training in patients with moderate chronic heart failure.
    Forissier JF; Vernochet P; Bertrand P; Charbonnier B; Monpère C
    Eur J Heart Fail; 2001 Jun; 3(3):335-42. PubMed ID: 11378005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
    Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
    Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure.
    Goldsmith RL; Bigger JT; Bloomfield DM; Krum H; Steinman RC; Sackner-Bernstein J; Packer M
    Am J Cardiol; 1997 Oct; 80(8):1101-4. PubMed ID: 9352991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide.
    Kobayakawa N; Sawaki D; Otani Y; Sekita G; Fukushima K; Takeuchi H; Aoyagi T
    Cardiovasc Drugs Ther; 2003 May; 17(3):295. PubMed ID: 14669748
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of carvedilol for heart failure.
    Delea TE; Vera-Llonch M; Richner RE; Fowler MB; Oster G
    Am J Cardiol; 1999 Mar; 83(6):890-6. PubMed ID: 10190405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol in the treatment of elderly patients with chronic heart failure.
    Witte KK; Clark AL
    Clin Interv Aging; 2008; 3(1):55-70. PubMed ID: 18488879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?
    Cleland JG
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():297-303. PubMed ID: 9211024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of mid- and long-term administration (3-4 years) of carvedilol in patients with idiopathic dilated cardiomyopathy].
    Metra M; Nodari S; Garbellini M; Boldi E; Rosselli F; Milan E; Giubbini R; Dei Cas L
    Cardiologia; 1997 May; 42(5):503-12. PubMed ID: 9289367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
    Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure.
    Metra M; Covolo L; Pezzali N; Zacà V; Bugatti S; Lombardi C; Bettari L; Romeo A; Gelatti U; Giubbini R; Donato F; Dei Cas L
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):49-60. PubMed ID: 20352314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
    Dunn CJ; Lea AP; Wagstaff AJ
    Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
    Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
    Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
    Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
    J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.